Post-Market Study of Comprehensive Reverse Augmented Glenoid and Mini Humeral Tray in Total Shoulder Arthroplasty
← catalyst calendarNCT03726554 · readout ≤ 1,289 d
Sponsored by Zimmer Biomet (industry) · ZBH — their whole pipeline →.
Phase
Not applicable
Status
Active, not recruiting
Study type
Interventional
Design
Non randomized · None · Treatment
Enrollment
99actual
Sites
6
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2018-08-28 | actual | When the study began enrolling |
| Primary completion | Feb 2030 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Feb 2030 | estimated | The whole study's end, after follow-up |
| First posted | 2018-10-31 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-07-09 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Arthropathy of Shoulder Region
- Grossly Deficient Rotator Cuff
- Osteoarthritis of the Shoulder
- Rheumatoid Arthritis Without Humeral Metaphyseal Defects
- Post-Traumatic Arthritis
Interventions
- Device: Comprehensive Reverse Porous Augmented Glenoid
- Device: Comprehensive Mini Humeral Tray
Primary outcome
what the primary-completion date above is the date OFImplant Survivorship
measured 10 years
Permalink · ZBH's whole pipeline · Catalyst calendar · Every registered study · What changed